Impact of HIV infection on the recurrence of tuberculosis in South India.

BACKGROUND There is limited information on the relative proportion of reactivation and reinfection at the time of recurrence among human immunodeficiency virus (HIV)-infected and HIV-uninfected patients who are successfully treated for tuberculosis infection in India. METHODS HIV-infected and HIV-uninfected patients with sputum culture-positive pulmonary tuberculosis were treated with short-course regimens and followed up for 36 months at the Tuberculosis Research Centre, South India. Bacteriologic recurrences were documented, and typing of strains was performed using 3 different genotypic techniques: restriction fragment length polymorphism (RFLP) by IS6110, spoligotyping, and mycobacterial interspersed repeat unit (MIRU)-variable number tandem repeat (VNTR). DNA fingerprints of paired Mycobacterium tuberculosis isolates (baseline and recurrence) were compared. RESULTS Among 44 HIV-infected and 30 HIV-uninfected patients with recurrent tuberculosis during the period July 1999 to October 2005, 25 and 23 paired isolates, respectively, were typed using all 3 methods. Recurrence was due to exogenous reinfection in 88% of HIV-infected and 9% of HIV-uninfected patients (P<.05). Among recurrent isolates, the HIV-infected patients showed more clustering, as well as a higher proportion of drug resistance, including multidrug resistance. CONCLUSIONS In India, a tuberculosis-endemic country, most recurrences after successful treatment of tuberculosis are due to exogenous reinfection in HIV-infected persons and endogenous reactivation in HIV-uninfected persons. Strategies for prevention and treatment of tuberculosis infection must take these findings into consideration.

[1]  P. Hopewell.  Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  S. Holmes,et al.  Genomic interrogation of ancestral Mycobacterium tuberculosis from south India. , 2008, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[3]  Nalin Rastogi,et al.  Proposal for Standardization of Optimized Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing of Mycobacterium tuberculosis , 2006, Journal of Clinical Microbiology.

[4]  C. Dye,et al.  Global tuberculosis control: surveillance planning financing. WHO report 2003. , 2003 .

[5]  B. D. de Jong,et al.  Treatment outcomes of patients with HIV and tuberculosis. , 2007, American journal of respiratory and critical care medicine.

[6]  S. Swaminathan,et al.  Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial. , 2010, American journal of respiratory and critical care medicine.

[7]  Nalin Rastogi,et al.  Predominant Tuberculosis Spoligotypes, Delhi, India , 2004, Emerging infectious diseases.

[8]  M. Raviglione,et al.  Global tuberculosis incidence and mortality during 1990-2000. , 1994, Bulletin of the World Health Organization.

[9]  S. Swaminathan,et al.  Risk of development of tuberculosis in HIV-infected patients. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[10]  C. Dye,et al.  Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Richard D Moore,et al.  Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil , 2008, AIDS.

[12]  Sa Azin,et al.  An overview on the 2008 UNAIDS Report on the 2008 UNAIDS Report on the Global AIDS Epidemic. , 2010 .

[13]  Chandrasekaran,et al.  Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[14]  A. Harries,et al.  Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1 , 2001, The Lancet.

[15]  R. Shafer,et al.  Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. , 1993, The New England journal of medicine.

[16]  T. Frieden,et al.  Molecular Epidemiology of Tuberculosis in a Rural Area of High Prevalence in South India: Implications for Disease Control and Prevention , 2002, Journal of Clinical Microbiology.

[17]  Giulia Marchetti,et al.  Molecular Epidemiology Study of Exogenous Reinfection in an Area with a Low Incidence of Tuberculosis , 2001, Journal of Clinical Microbiology.

[18]  O Afonso,et al.  Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. , 2001, American journal of respiratory and critical care medicine.

[19]  A. Mohan,et al.  HIV-TB co-infection: epidemiology, diagnosis & management. , 2005, The Indian journal of medical research.

[20]  R. Frothingham,et al.  Comparison of Methods Based on Different Molecular Epidemiological Markers for Typing of Mycobacterium tuberculosis Complex Strains: Interlaboratory Study of Discriminatory Power and Reproducibility , 1999, Journal of Clinical Microbiology.

[21]  S. Lawn,et al.  Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[22]  S. Swaminathan,et al.  Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy. , 2008, The National medical journal of India.

[23]  Epco Hasker,et al.  Recurrence in tuberculosis: relapse or reinfection? , 2003, The Lancet. Infectious diseases.

[24]  I. Baess.  Isolation and purification of deoxyribonucleic acid from mycobacteria. , 2009, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.

[25]  C. Martín,et al.  Recurrent tuberculosis from 1992 to 2004 in a metropolitan area , 2007, European Respiratory Journal.

[26]  S. Swaminathan,et al.  Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[27]  P. Sonnenberg,et al.  HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers , 2001, The Lancet.

[28]  R. Chaisson,et al.  Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy? , 2003, AIDS.

[29]  R. Chaisson,et al.  Contribution of reinfection to recurrent tuberculosis in South African gold miners. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[30]  A. Van Deun,et al.  Rifampin and recurrence of tuberculosis among patients infected with HIV. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  R. Chaisson,et al.  Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons. , 1999, AIDS.

[32]  S. Narayanan,et al.  Restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, India, by use of direct-repeat probe , 1995, Journal of clinical microbiology.

[33]  Nalin Rastogi,et al.  Genotyping of the Mycobacterium tuberculosis complex using MIRUs: association with VNTR and spoligotyping for molecular epidemiology and evolutionary genetics. , 2003, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[34]  J. T. Crawford,et al.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology , 1993, Journal of clinical microbiology.

[35]  W. El-Sadr,et al.  A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  Sindhu Ravindran,et al.  Characterization of Ancestral Mycobacterium tuberculosis by Multiple Genetic Markers and Proposal of Genotyping Strategy , 2004, Journal of Clinical Microbiology.